Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(36 sites)
Austria
Investigative Site, Innsbruck Investigative Site, Vienna France
Investigative Site, Bobigny Investigative Site, Clichy Investigative Site, Créteil Investigative Site, Le Chesnay Investigative Site, Limoges Investigative Site, Montpellier Investigative Site, Pessac Investigative Site, Rennes Investigative Site, Toulouse Investigative Site, Villejuif Germany
Investigative Site, Berlin Investigative Site, Essen Investigative Site, Frankfurt am Main Investigative Site, Hanover Italy
Investigative Site, Bergamo Investigative Site, Milan Investigative Site, Milan Investigative Site, Torino Romania
Investigative Site, Bucharest Investigative Site, Bucharest Investigative Site, Bucharest Investigative Site, Craiova Spain
Investigative Site, Barcelona Investigative Site, Barcelona Investigative Site, Madrid Investigative Site, Madrid Investigative Site, Santander United Kingdom
Investigative Site, London Investigative Site, London Investigative Site, London Investigative Site, Manchester Investigative Site, Nottingham